IDXX — IDEXX Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $44.88bn
- $45.43bn
- $3.66bn
- 98
- 11
- 84
- 69
Annual cashflow statement for IDEXX Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 428 | 582 | 745 | 679 | 845 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 42.2 | 39.8 | 47 | 60.6 | 67.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -105 | -31.8 | -138 | -274 | -72.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 459 | 648 | 756 | 543 | 907 |
| Capital Expenditures | -155 | -108 | -120 | -159 | -134 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -50.3 | -1.5 | -173 | -36.5 | 8.38 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -206 | -109 | -293 | -195 | -125 |
| Financing Cash Flow Items | -10.6 | -27.3 | -20.7 | -17.5 | -13.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -286 | -248 | -697 | -371 | -442 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -33.5 | 294 | -239 | -31.9 | 341 |